Q2 2017 13F Holders as of 30 Jun 2017
-
Type / Class
-
Equity / Common Stock, $0.0001 par value per share
-
Shares outstanding
-
106M
-
Number of holders
-
186
-
Total 13F shares, excl. options
-
42.7M
-
Shares change
-
+1.93M
-
Total reported value, excl. options
-
$1.44B
-
Value change
-
+$80.8M
-
Put/Call ratio
-
0.79
-
Number of buys
-
106
-
Number of sells
-
-70
-
Price
-
$33.71
Significant Holders of Sarepta Therapeutics, Inc. - Common Stock, $0.0001 par value per share (SRPT) as of Q2 2017
246 filings reported holding SRPT - Sarepta Therapeutics, Inc. - Common Stock, $0.0001 par value per share as of Q2 2017.
Sarepta Therapeutics, Inc. - Common Stock, $0.0001 par value per share (SRPT) has 186 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 42.7M shares
of 106M outstanding shares and own 40.44% of the company stock.
Largest 10 shareholders include BlackRock Inc. (5.22M shares), VANGUARD GROUP INC (4.26M shares), STATE STREET CORP (3.17M shares), HealthCor Management, L.P. (2.03M shares), Point72 Asset Management, L.P. (2.03M shares), Tourbillon Capital Partners, L.P. (1.93M shares), MILLENNIUM MANAGEMENT LLC (1.36M shares), Camber Capital Management LLC (1.3M shares), PERCEPTIVE ADVISORS LLC (1.09M shares), and FMR LLC (1.09M shares).
This table shows the top 186 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.